Market Research Logo

Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy (ddPCR, DHPLC)), Research Area (Proteomics, Lipidomics), Application (Biomarker Validation, Biomarker Discovery) - Global Foreca

Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy (ddPCR, DHPLC)), Research Area (Proteomics, Lipidomics), Application (Biomarker Validation, Biomarker Discovery) - Global Forecast to 2022

“The biomarker technologies market is projected to grow at a CAGR of 9.7%.”
The biomarker technologies market is expected to reach USD 74.51 billion in 2022 from USD 46.97 billion in 2017, at a CAGR of 9.7% during the forecast period
The growth of this market is mainly driven by increasing healthcare expenditure and the increase in R&D funding. Other important factors aiding the growth of this market include the increasing utility of biomarkers for diagnostic purposes and new initiatives for biomarker research. Moreover, the emergence of companion diagnostics (CDx) has further intensified biomarker R&D activities. However, significant capital investments are required for the discovery, development, and validation of biomarkers. This is a major factor restraining the growth of the biomarker technologies market.

Immunoassays held the largest share of the biomarker technologies market, by profiling technology, in 2017.
Based on profiling technology, the biomarker technologies market is classified into immunoassay, PCR, imaging technology, mass spectrometry, NGS, chromatography, cytogenetics, and other technologies. The immunoassay segment accounted for the largest share of the market. This segment is further divided into the ELISA, western blot, and protein microarray segment. The protein microarray segment is expected to grow at the fastest pace during the forecast period, mainly due to its increasing use in drug discovery. Moreover, it reduces the time taken, costs, and reagent consumption. This market is driven by advances in the field of proteomics and improvements in the field of recombinant proteins.

Genomics held the largest share of the biomarker technologies market, by research area, in 2017
Based on research area, this market is classified into genomics, proteomics, metabolomics, and other research areas. The focus on biomarker research in the field of genomics is growing with the advent of innovative technologies such as NGS, microarrays, and dPCR; this is supporting market growth.

Cancer was estimated to dominate the biomarker technologies market, by disease indication, in 2017
Based on disease indication, the biomarker technologies market is classified into cancer, infectious diseases, autoimmune disorders, neurological disorders, cardiovascular disorders, and other disease indications. Cancer accounted for the largest share of the biomarker technologies market, as biomarkers have major applications in cancer research, diagnostics, and treatment.

Break-up profile of primaries:
By Company Type: Tier 1-42%, Tier 2-37%, and Tier 3-21%.
By Designation: C-level-34%, D-level-42%, and Others-24%
By Region: North America-32%, Europe-30%, Asia-24%, and RoW-14%
The key players in this market are Agilent Technologies (US), Thermo Fisher Scientific (US), Roche (Switzerland), Waters Corporation (US), Danaher Corporation (US), Shimadzu Corporation (Japan), and Bio-Rad Laboratories (US).

Research Coverage:
In this report, the biomarker technologies market is segmented by test type, product, application, profiling technology, disease indication, system, and research type. Specific segments have also been studied based on application—clinical diagnostics, drug discovery & development, and applied research. The biomarker systems market has also been classified based on products used.

Reasons to buy this report:
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the portfolios of the top players in the biomarker technologies market. The report analyzes the market by test type, product, application, profiling technology, disease indication, system, research type, and region.

Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the biomarker technologies market.

Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for biomarker technologies market products across regions.

Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the biomarker technologies market.

Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of key players in the biomarker technologies market for mass spectrometry and chromatography.


  • INTRODUCTION
    • BIOMARKERS MARKET OVERVIEW
    • OPPORTUNITIES FOR INNOVATORS IN BIOMARKER RESEARCH
      • INNOVATORS
      • MASS SPECTROMETRY
      • MASS CYTOMETRY
      • MASS SPECTROMETRY IMAGING
      • MASS SPECTROMETRY
      • KEY TECHNOLOGICAL DEVELOPMENTS FOR NOVEL MS-BASED BIOMARKER DISCOVERY
  • RESEARCH METHODOLOGY
  • BIOMARKER TECHNOLOGIES MARKET, BY TEST TYPE, 2016-2022 (USD BILLION)
    • INTRODUCTION
    • CONVENTIONAL TESTING VS. LIQUID BIOPSY TESTING
    • SOLID BIOPSY VS. LIQUID BIOPSY TESTING
    • CONVENTIONAL TESTING VS LIQUID BIOPSY TESTING
      • NOVEL TECHNOLOGIES IN LIQUID BIOPSY RESEARCH
      • NGS VS DIGITAL PCR
      • MASS SPECTROSCOPY VS IMMUNOASSAY:
      • FLOW CYTOMETRY VS CELLSEARCH SYSTEM:
      • INNOVATORS
      • CTDNA PLATFORMS FOR DETECTION OF EGFR MUTATIONS
      • COMMERCIALLY AVAILABLE LIQUID BIOPSY ASSAYS
        • Table GLOBAL BIOMARKERS TESTS MARKET, BY REGION, 2015-2022 (USD BILLION)
        • Table NORTH AMERICA: BIOMARKERS TESTS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
        • Table GLOBAL BIOMARKERS MARKET, BY TEST TYPE, 2015-2022 (USD BILLION)
    • CAN TISSUE BIOPSY BE REPLACED BY LIQUID BIOPSY?
  • BIOMARKERS LIQUID BIOPSY MARKET, BY APPLICATION, 2016-2022 (USD BILLION)
    • BIOMARKERS MARKET FOR LIQUID BIOPSY, CLINICAL DIAGNOSTICS
      • Table GLOBAL BIOMARKERS LIQUID BIOPSY MARKET, BY APPLICATION, 2017-2022 (USD BILLION)
  • LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2016-2022 (USD BILLION)
    • LIQUID BIOPSY MARKET, ddPCR
      • NGS Vs ddPCR FOR LIQUID BIOPSY
        • Table GLOBAL BIOMARKERS LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2017-2022 (USD BILLION)
      • LIQUID BIOPSY MARKET, MASS SPECTROMETRY
      • LIQUID BIOPSY MARKET, DHPLC
  • BIOMARKER TECHNOLOGIES MARKET, BY PRODUCTS, 2016-2022 (USD BILLION)
    • Table GLOBAL BIOMARKERS MARKET, BY PRODUCT, 2015-2022 (USD BILLION)
    • Table GLOBAL BIOMARKERS CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD BILLION)
    • Table GLOBAL BIOMARKERS PRODUCTS MARKET, BY REGION, 2015-2022 (USD BILLION)
    • Table NORTH AMERICA: BIOMARKERS PRODUCTS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
    • Table GLOBAL CONSUMABLES MARKET, BY REGION, 2015-2022 (USD BILLION)
    • Table GLOBAL REAGENTS & KITS MARKET, BY REGION, 2015-2022 (USD BILLION)
    • Table NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
    • Table GLOBAL CHROMATOGRAPHY COLUMNS MARKET, BY REGION, 2015-2022 (USD BILLION)
    • BIOMARKER DISCOVERY: RESEARCH PROCESS
      • Table GLOBAL INSTRUMENTS MARKET, BY REGION, 2015-2022 (USD BILLION)
      • Table NORTH AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
      • Table GLOBAL SERVICES MARKET, BY REGION, 2015-2022 (USD BILLION)
      • Table NORTH AMERICA: SERVICES MARKET, BY REGION, 2015-2022 (USD BILLION)
      • Table GLOBAL SOFTWARE/INFORMATICS MARKET, BY REGION, 2015-2022 (USD BILLION)
      • Table NORTH AMERICA: SOFTWARE/INFORMATICS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • BIOMARKER PRODUCT MARKET, BY APPLICATION, 2016-2022 (USD BILLION)
    • Table GLOBAL CONSUMABLES MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
    • Table GLOBAL CONSUMABLES MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
    • Table GLOBAL CONSUMABLES MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
    • Table GLOBAL CONSUMABLES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
    • Table GLOBAL INSTRUMENTS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
    • Table GLOBAL INSTRUMENTS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
    • Table GLOBAL INSTRUMENTS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
    • Table GLOBAL INSTRUMENTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
    • Table GLOBAL SERVICES MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
    • Table GLOBAL SERVICES MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
    • Table GLOBAL SERVICES MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
    • Table GLOBAL SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
    • Table GLOBAL SOFTWARE/INFORMATICS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
    • Table GLOBAL SOFTWARE/INFORMATICS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
    • Table GLOBAL SOFTWARE/INFORMATICS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
    • Table GLOBAL SOFTWARE/INFORMATICS MARKET FOR DRUG DEVELOPMENT & DISCOVERY, BY REGION, 2015-2022 (USD BILLION)
  • BIOMARKER TECHNOLOGIES MARKET, BY PROFILING TECHNOLOGY, 2016-2022 (USD BILLION)
    • Table GLOBAL BIOMARKERS MARKET, BY PROFILING TECHNOLOGY, 2015-2022 (USD BILLION)
    • Table GLOBAL BIOMARKERS MARKET FOR IMMUNOASSAYS, BY TYPE, 2015-2022 (USD BILLION)
    • Table GLOBAL BIOMARKERS MARKET FOR PROFILING TECHNOLOGIES, BY REGION, 2015-2022 (USD BILLION)
    • Table NORTH AMERICA: BIOMARKERS MARKET FOR PROFILING TECHNOLOGIES, BY COUNTRY, 2015-2022 (USD BILLION)
    • Table GLOBAL IMMUNOASSAYS MARKET, BY REGION, 2015-2022 (USD BILLION)
    • Table GLOBAL ELISA MARKET, BY REGION, 2015-2022 (USD BILLION)
    • Table NORTH AMERICA: IMMUNOASSAYS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
    • Table GLOBAL ELISA MARKET, BY REGION, 2015-2022 (USD BILLION)
    • Table GLOBAL WESTERN BLOT MARKET, BY REGION, 2015-2022 (USD BILLION)
    • Table GLOBAL PROTEIN MICROARRAY MARKET, BY REGION, 2015-2022 (USD BILLION)
    • Table NORTH AMERICA: WESTERN BLOT MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
    • Table GLOBAL PROTEIN MICROARRAY MARKET, BY REGION, 2015-2022 (USD BILLION)
    • Table KEY EVOLUTIONARY MILESTONES IN THE FIELD OF QPCR/DPCR
    • Table GLOBAL PCR MARKET, BY REGION, 2015-2022 (USD BILLION)
    • Table NORTH AMERICA: PCR MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
    • PRIMARY INSIGHTS
      • CHRONOLOGY OF MASS SPECTROMETRY DEVELOPMENT MASS SPECTROMETRY
        • Table GLOBAL MASS SPECTROMETRY MARKET, BY REGION, 2015-2022 (USD BILLION)
        • Table NORTH AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
        • Table LIST OF SEQUENCING PLATFORMS LAUNCHED BY MARKET PLAYERS DURING 2015-2017
        • Table GLOBAL NGS MARKET, BY REGION, 2015-2022 (USD BILLION)
        • Table NORTH AMERICA: NGS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
        • Table GLOBAL CHROMATOGRAPHY MARKET, BY REGION, 2015-2022 (USD BILLION)
        • Table NORTH AMERICA: CHROMATOGRAPHY MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
    • PRIMARY INSIGHTS
      • Table GLOBAL IMAGING TECHNOLOGY MARKET, BY REGION, 2015-2022 (USD BILLION)
      • Table GLOBAL CYTOGENETICS MARKET, BY REGION, 2015-2022 (USD BILLION)
      • Table NORTH AMERICA: IMAGING TECHNOLOGY MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
      • Table NORTH AMERICA: CYTOGENETICS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
      • Table GLOBAL BIOMARKERS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2015-2022 (USD BILLION)
      • Table NORTH AMERICA: BIOMARKERS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2015-2022 (USD BILLION)
  • BIOMARKER PROFILING TECHNOLOGIES MARKET, BY APPLICATION, 2016-2022 (USD BILLION)
    • Table GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR IMMUNOASSAY, BY APPLICATION, 2017-2022 (USD BILLION)
    • Table GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR PCR, BY APPLICATION, 2017-2022 (USD BILLION)
    • Table GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR MASS SPECTROMETRY, BY APPLICATION, 2017-2022 (USD BILLION)
    • APPLICATIONS OF NGS IN CLINICAL TRIALS AND CLINICAL PRACTICE
      • Table GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR NGS, BY APPLICATION, 2017-2022 (USD BILLION)
      • Table GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR IMAGING TECHNOLOGY, BY APPLICATION, 2017-2022 (USD BILLION)
      • Table GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR CYTOGENETICS, BY APPLICATION, 2017-2022 (USD BILLION)
      • Table GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR OTHER TECHNOLOGIES, BY APPLICATION, 2017-2022 (USD BILLION)
  • GLOBAL BIOMARKER DISEASE INDICATION MARKET, BY APPLICATION (USD BILLION)
    • Table GLOBAL BIOMARKERS MARKET, BY DISEASE INDICATION, 2015-2022 (USD BILLION)
    • Table GLOBAL CANCER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
    • Table NORTH AMERICA: CANCER BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
    • Table GLOBAL CANCER BIOMARKERS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
    • Table GLOBAL CANCER BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
    • Table GLOBAL CANCER BIOMARKERS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
    • Table GLOBAL CANCER BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
    • ANALYSIS OF SERUM SAMPLE FROM TWO COUNTRIES TO DIFFERENTIATE METABOLOMICS BIOMARKER IN DENGUE VIRUS INFECTION (DVI)
      • Table GLOBAL INFECTIOUS DISEASE BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
      • Table GLOBAL INFECTIOUS DISEASE BIOMARKERS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
      • Table GLOBAL INFECTIOUS DISEASE BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
      • Table GLOBAL INFECTIOUS DISEASE BIOMARKERS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
      • Table GLOBAL INFECTIOUS DISEASE BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
    • PRIMARY INSIGHTS
      • Table GLOBAL AUTOIMMUNE DISORDER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
      • Table NORTH AMERICA: AUTOIMMUNE DISORDER BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
      • Table GLOBAL AUTOIMMUNE DISORDER BIOMARKERS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
      • Table GLOBAL AUTOIMMUNE DISORDER BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
      • Table GLOBAL AUTOIMMUNE DISORDER BIOMARKERS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
      • Table GLOBAL AUTOIMMUNE DISORDER BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
      • Table GLOBAL NEUROLOGICAL DISORDER BIOMARKERS MARKET, BY TYPE, 2015-2022 (USD BILLION)
      • Table GLOBAL NEUROLOGICAL DISORDER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
      • Table NORTH AMERICA: NEUROLOGICAL DISORDER BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
      • Table GLOBAL DEGENERATIVE DISORDER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
      • Table GLOBAL OTHER NEUROLOGICAL DISORDER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
      • Table GLOBAL DEGENERATIVE DISORDER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
      • Table GLOBAL OTHER NEUROLOGICAL DISORDER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
      • Table GLOBAL NEUROLOGICAL DISORDER BIOMARKERS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
      • Table GLOBAL NEUROLOGICAL DISORDER BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
      • Table GLOBAL NEUROLOGICAL DISORDER BIOMARKERS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
      • Table GLOBAL NEUROLOGICAL DISORDER BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
      • Table GLOBAL CARDIOVASCULAR DISEASE BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
      • Table NORTH AMERICA: CARDIOVASCULAR DISEASE BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
      • Table GLOBAL CARDIOVASCULAR DISEASE BIOMARKERS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
      • Table GLOBAL CARDIOVASCULAR DISEASE BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
      • Table GLOBAL CARDIOVASCULAR DISEASE BIOMARKERS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
      • Table GLOBAL CARDIOVASCULAR DISEASE BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
      • Table GLOBAL OTHER DISEASE BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
      • Table NORTH AMERICA: OTHER DISEASE BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
      • Table GLOBAL OTHER DISEASE BIOMARKERS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
      • Table GLOBAL OTHER DISEASE BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
      • Table GLOBAL OTHER DISEASE BIOMARKERS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
      • Table GLOBAL OTHER DISEASE BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • BIOMARKER TECHNOLOGIES MARKET, BY APPLICATION, 2016-2022 (USD BILLION)
    • Table GLOBAL BIOMARKERS MARKET, BY SYSTEM, 2015-2022 (USD BILLION)
    • Table GLOBAL BIOMARKER IDENTIFICATION, VALIDATION & DEVELOPMENT RESEARCH MARKET, BY REGION, 2015-2022 (USD BILLION)
    • Table GLOBAL ROUTINE BIOMARKER-BASED TESTS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • BIOMARKER TECHNOLOGY APPLICATIONS MARKET, BY PRODUCT, 2016-2022 (USD BILLION)
    • Table BIOMARKER IDENTIFICATION, VALIDATION AND DEVELOPMENT RESEARCH, BY PRODUCT, 2017-2022 (USD BILLION)
    • Table ROUTINE BIOMARKER BASED TEST / ASSAYS FOR CLINICAL USE, BY PRODUCT, 2017-2022 (USD BILLION)
  • BIOMARKER TECHNOLOGIES MARKET, BY RESEARCH AREA, 2016-2022 (USD BILLION)
    • BIOMARKER RESEARCH: MAJOR TECHNOLOGIES USED
      • Table GLOBAL BIOMARKERS MARKET, BY RESEARCH TYPE, 2015-2022 (USD BILLION)
      • Table GLOBAL BIOMARKER IDENTIFICATION, VALIDATION AND DEVELOPMENT RESEARCH MARKET, BY RESEARCH TYPE, 2015-2022 (USD BILLION)
      • Table GLOBAL GENOMICS MARKET, BY REGION, 2015-2022 (USD BILLION)
      • Table GLOBAL PROTEOMICS MARKET, BY REGION, 2015-2022 (USD BILLION)
    • BIOMARKER RESEARCH: CURRENTLY USED PROTEIN ARRAYS FOR CANCER BIOMARKER DISCOVERY
      • Table GLOBAL METABOLOMICS MARKET, BY TYPE, 2015-2022 (USD BILLION)
      • Table GLOBAL METABOLOMICS MARKET, BY REGION, 2015-2022 (USD BILLION)
      • Table GLOBAL LIPIDOMICS MARKET, BY REGION, 2015-2022 (USD MILLION)
      • Table GLOBAL METABOLIC FLUX MARKET, BY REGION, 2015-2022 (USD BILLION)
      • Table GLOBAL OTHER METABOLOMICS MARKET, BY REGION, 2015-2022 (USD BILLION)
    • BIOMARKER RESEARCH: OVERVIEW OF SEQUENCING-BASED METHODS TO CHARACTERIZE THE MICROBIOME
    • BIOMARKER RESEARCH: METAPROTEOMIC TECHNOLOGIES
      • Table GLOBAL MICROBIOME MARKET, BY REGION, 2015-2022 (USD MILLION)
    • BIOMARKER RESEARCH: METABOLITES ASSOCIATED WITH DISEASES AND RELATIVE METABOLOMIC PLATFORMS
      • Table GLOBAL OTHER RESEARCH TYPES MARKET, BY REGION, 2015-2022 (USD BILLION)
  • MARKET SHARE ANALYSIS (2017)
    • Table STRENGTH OF PRODUCT PORTFOLIO (KEY PLAYERS)
    • Table BUSINESS STRATEGY EXCELLENCE (KEY PLAYERS)
    • Table STRENGTH OF PRODUCT PORTFOLIO (KEY PLAYERS)
    • Table BUSINESS STRATEGY EXCELLENCE (KEY PLAYERS)
  • BIOMARKER TECHNOLOGIES MARKET, BY REGION, 2016-2022 (USD BILLION)
    • Table GLOBAL BIOMARKER MARKET, BY REGION, 2015-2022 (USD BILLION)
    • Table NORTH AMERICA: BIOMARKER MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
    • ASIA PACIFIC
    • CHINA
    • INDIA
    • AUTHORS DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report